Trial Profile
An Open-label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines in Treatment-refractory Patients With Unipolar Depression or Generalized Anxiety Disorder and Chronic Benzodiazepine Use
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Depression; Generalised anxiety disorder
- Focus Therapeutic Use
- 02 Dec 2010 New trial record